Publication | Closed Access

Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment

Alzheimer's DiseaseCholine Metabolite ChangesMedicineDementiaNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeuroscienceNeurologyNeurodegenerationMild Cognitive ImpairmentDisease PatientsPharmacologyNeurochemistryBrain PathologyLewy Body Dementia